V. Nataf

2.1k total citations
61 papers, 1.5k citations indexed

About

V. Nataf is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, V. Nataf has authored 61 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Radiology, Nuclear Medicine and Imaging, 18 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in V. Nataf's work include Medical Imaging Techniques and Applications (14 papers), Radiopharmaceutical Chemistry and Applications (14 papers) and Prostate Cancer Diagnosis and Treatment (11 papers). V. Nataf is often cited by papers focused on Medical Imaging Techniques and Applications (14 papers), Radiopharmaceutical Chemistry and Applications (14 papers) and Prostate Cancer Diagnosis and Treatment (11 papers). V. Nataf collaborates with scholars based in France, Slovakia and Monaco. V. Nataf's co-authors include Nicole M. Le Douarin, Jean‐Noël Talbot, Anne Eichmann, Soňa Balogová, Virginie Huchet, Pierre Vaigot, Christiane Bréant, C. Corbel, Khaldoun Kerrou and Françoise Montravers and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

V. Nataf

59 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Nataf France 21 530 336 298 247 247 61 1.5k
Christopher L. Tinkle United States 17 702 1.3× 127 0.4× 654 2.2× 264 1.1× 198 0.8× 58 1.9k
Arthur H. Tatum United States 24 433 0.8× 247 0.7× 448 1.5× 280 1.1× 89 0.4× 50 1.7k
Günther Stockhammer Austria 21 824 1.6× 458 1.4× 535 1.8× 336 1.4× 58 0.2× 43 2.2k
Andrew Sizeland Australia 22 1.5k 2.8× 202 0.6× 667 2.2× 177 0.7× 245 1.0× 40 2.4k
Dan S. Gombos United States 22 457 0.9× 313 0.9× 624 2.1× 414 1.7× 44 0.2× 87 1.9k
Steven C. Ziesmer United States 35 580 1.1× 189 0.6× 1.2k 4.0× 197 0.8× 87 0.4× 65 3.2k
Toru Nishi Japan 25 750 1.4× 95 0.3× 226 0.8× 236 1.0× 144 0.6× 70 2.0k
Kazufumi Sato Japan 23 759 1.4× 102 0.3× 471 1.6× 235 1.0× 121 0.5× 82 2.1k
Scott M. Norberg United States 15 945 1.8× 149 0.4× 648 2.2× 422 1.7× 153 0.6× 35 2.0k
Colette Deminière France 21 363 0.7× 303 0.9× 196 0.7× 416 1.7× 47 0.2× 77 1.6k

Countries citing papers authored by V. Nataf

Since Specialization
Citations

This map shows the geographic impact of V. Nataf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Nataf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Nataf more than expected).

Fields of papers citing papers by V. Nataf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Nataf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Nataf. The network helps show where V. Nataf may publish in the future.

Co-authorship network of co-authors of V. Nataf

This figure shows the co-authorship network connecting the top 25 collaborators of V. Nataf. A scholar is included among the top collaborators of V. Nataf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Nataf. V. Nataf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Serrano, Benjamín, Florent Hugonnet, F. Berthier, et al.. (2023). Quantitative analysis of 99mTc-pertechnetate thyroid uptake with a large-field CZT gamma camera: feasibility and comparison between SPECT/CT and planar acquisitions. EJNMMI Physics. 10(1). 45–45. 4 indexed citations
2.
Perrin, Christophe, Gilles Chironi, F. Berthier, et al.. (2022). Microvascular injuries, secondary edema, and inconsistencies in lung vascularization between affected and nonaffected pulmonary segments of non-critically ill hospitalized COVID-19 patients presenting with clinical deterioration. Therapeutic Advances in Respiratory Disease. 16. 2673675368–2673675368. 2 indexed citations
3.
Montemagno, Christopher, Benjamín Serrano, Jérôme Durivault, et al.. (2021). In vivo monitoring of the therapeutic efficacy of a CXCR1/2 inhibitor with 18F-FDG PET/CT imaging in experimental head and neck carcinoma: A feasibility study. Biochemistry and Biophysics Reports. 27. 101098–101098. 2 indexed citations
4.
Ohnona, Jessica, V. Nataf, Mathieu Gauthé, et al.. (2018). Prognostic value of functional tumor burden on 68Ga-DOTATOC PET/CT in patients with pancreatic neuro-endocrine tumors. Neoplasma. 66(1). 140–148. 12 indexed citations
5.
Huchet, Virginie, Caroline Rousseau, Alexandre Cochet, et al.. (2018). 18F-fluorocholine PET/CT in patients with occult biochemical recurrence of prostate cancer: Detection rate, impact on management and adequacy of impact. A prospective multicentre study. PLoS ONE. 13(2). e0191487–e0191487. 14 indexed citations
6.
Gauthé, Mathieu, Fernando Ruíz Santiago, Jessica Ohnona, et al.. (2018). Vertebral metastases from neuroendocrine tumours: How to avoid false positives on 68Ga-DOTA-TOC PET using CT pattern analysis?. European Radiology. 28(9). 3943–3952. 11 indexed citations
7.
Zhang-Yin, Jules, Myriam Sasanelli, V. Nataf, et al.. (2017). Equivalent Dose Rate 1 Meter from Neuroendocrine Tumor Patients Exiting the Nuclear Medicine Department After Undergoing Imaging. Journal of Nuclear Medicine. 58(8). 1230–1235. 9 indexed citations
8.
Balogová, Soňa, V. Nataf, Virginie Huchet, et al.. (2016). 18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study. European Journal of Nuclear Medicine and Molecular Imaging. 43(11). 1995–2004. 49 indexed citations
9.
Prignon, Aurélie, V. Nataf, C. Provost, et al.. (2014). 68Ga-AMBA and 18F-FDG for preclinical PET imaging of breast cancer: effect of tamoxifen treatment on tracer uptake by tumor. Nuclear Medicine and Biology. 42(2). 92–98. 20 indexed citations
10.
Hodolič, Marina, Virginie Huchet, Soňa Balogová, et al.. (2013). Incidental uptake of 18 F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer. Radiology and Oncology. 48(3). 228–234. 42 indexed citations
11.
Balogová, Soňa, Jean‐Noël Talbot, V. Nataf, et al.. (2013). 18F-Fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type. European Journal of Nuclear Medicine and Molecular Imaging. 40(6). 943–966. 86 indexed citations
12.
Nataf, V., Khaldoun Kerrou, Soňa Balogová, et al.. (2010). TEP à la fluoroéthyltyrosine (18F) pour la détection des tumeurs cérébrales. Bulletin du Cancer. 97(5). 495–506. 1 indexed citations
13.
Montravers, Françoise, Khaldoun Kerrou, Virginie Huchet, V. Nataf, & Jean‐Noël Talbot. (2008). Evaluation of the impact of FDOPA-PET on the management of patients referred for pheochromocytoma. 49(6). 1669–77. 1 indexed citations
14.
Aide, Nicolas, Laurent Poulain, Mélanie Briand, et al.. (2008). Early evaluation of the effects of chemotherapy with longitudinal FDG small-animal PET in human testicular cancer xenografts: early flare response does not reflect refractory disease. European Journal of Nuclear Medicine and Molecular Imaging. 36(3). 396–405. 18 indexed citations
15.
Talbot, Jean‐Noël, et al.. (2006). Bases de la TEP et de la TEP/TDM: machines et médicaments radiopharmaceutiques pour le diagnostic clinique. La Presse Médicale. 35(9). 1331–1337. 2 indexed citations
16.
Nataf, V., et al.. (1998). The expression patterns of endothelin-A receptor and endothelin 1 in the avian embryo. Mechanisms of Development. 75(1-2). 145–149. 28 indexed citations
17.
Nataf, V., et al.. (1998). The expression pattern of endothelin 3 in the avian embryo. Mechanisms of Development. 73(2). 217–220. 47 indexed citations
18.
Nataf, V., Pascale Mercier, Béatrice de Néchaud, et al.. (1995). Melanoblast/Melanocyte Early Marker (MelEM) Is a Glutathione S-Transferase Subunit. Experimental Cell Research. 218(1). 394–400. 7 indexed citations
19.
Nataf, V. & Solange Monier. (1992). Effect of insulin and insulin-like growth factor I on the expression of the catecholaminergic phenotype by neural crest cells. Developmental Brain Research. 69(1). 59–66. 25 indexed citations
20.
Nataf, V., et al.. (1990). Modulation of sulfated proteoglycan synthesis and collagen gene expression by chondrocytes grown in the presence of bFGF alone or combined with IGF1. annales de biologie animale biochimie biophysique. 30(3). 331–342. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026